Evolution of FIB-4 score in SpA and PsA patients taking anti-TNF or anti-IL17 - 24/11/24
Doi : 10.1016/j.jbspin.2024.105763
Frank Verhoeven a, b, ⁎ 
, Clément Prati a, b, Vincent Di Martino b, c, Thierry Thevenot b, c, Céline Demougeot b, Daniel Wendling a, b, Delphine Weil-Verhoeven b, c
, Clément Prati a, b, Vincent Di Martino b, c, Thierry Thevenot b, c, Céline Demougeot b, Daniel Wendling a, b, Delphine Weil-Verhoeven b, c a Department of Rheumatology, CHRU of Besançon, Besançon, France
b Université de Franche-Comté, EFS, Inserm, UMR RIGHT, 25000 Besançon, France
c Department of Hepatology, CHRU of Besançon, Besançon, France
⁎Corresponding author: Rhumatologie, CHRU Jean-Minjoz, 2, boulevard Fleming, 25030 Besançon, France.Rhumatologie, CHRU Jean-Minjoz2, boulevard FlemingBesançon25030France
Highlights |
• | In axial spondyloarthritis, anti-TNF and anti-IL17 do not increase the FIB-4 score after two years. |
• | In psoriatic arthritis, anti-IL17 but not anti-TNF increases the FIB-4 score after two years. |
Keywords : Axial spondyloarthritis, Psoriatic arthritis, Liver tolerance, bDMARDs, FIB-4
Mappa
© 2024
Sociýtý Franýaise de Rhumatologie. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 91 - N° 6
Articolo 105763- Dicembre 2024 Ritorno al numero
Articolo precedente
- Interest in various treatments for osteoarthritis among the French population: A Google Trends analysis
- Olivier Fakih, Frank Verhoeven, Clément Prati, Daniel Wendling
- Successful treatment with dupilumab of adult-onset asthma and periocular xanthogranuloma syndrome overlapping IgG4-related disease
- Lucile Sesé, Michael Soussan, Yurdagül Uzunhan, Jonathan London, Olivia Freynet, Flora Finet, Robin Dhote, Sébastien Abad
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?